HOOPER ANTHONY C
SEC CIK 1277244 · EDGAR
BoughtSold
Most active insiders at ONC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OYLER JOHN | CEO, Dir | — | $327.88M |
| 2 | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | — | $13.37M |
| 3 | Wu Xiaobin | Pres, COO | — | $8.75M |
| 4 | Lee Chan Henry | SVP, GC | — | $7.95M |
| 5 | Wang Lai | Pres, Gbl Head of R, D | — | $1.17M |
| 6 | Sanders Corazon (Corsee) D. | Dir | — | $961.2K |
| 7 | Rosenberg Aaron | CFO | — | $524.4K |
| 8 | BAKER BROS. ADVISORS LP | Dir | — | $262.0K |
| 9 | Ball Titus B. | Principal Accounting Off | — | $127.3K |
| 10 | Dugan Margaret | Dir | — | $65.6K |
| 17 | HOOPER ANTHONY C | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 17:50 | 2026-06-11 | ONC | BeOne Medicines Ltd. | HOOPER ANTHONY C | Dir | A - Grant | $0.00 | +19.0K | 83.7K | +29% | $0 | |
| 2026-03-03 | 2026-03-01 | MNKD | MANNKIND CORP | HOOPER ANTHONY C | Dir | A - Grant | $3.27 | +35.0K | 236.2K | +17% | +$114.5K | |
| D | 2025-05-22 | 2025-05-21 | ONC | BeOne Medicines Ltd. | HOOPER ANTHONY C | Dir | A - Grant | $0.00 | +11.0K | 64.7K | +20% | $0 |
| D | 2025-05-16 | 2025-05-14 | MNKD | MANNKIND CORP | HOOPER ANTHONY C | Dir | A - Grant | $4.56 | +25.0K | 201.2K | +14% | +$114.0K |
| D | 2024-06-07 | 2024-06-05 | ONC | BeOne Medicines Ltd. | HOOPER ANTHONY C | Dir | A - Grant | $0.00 | +16.3K | 53.8K | +44% | $0 |
| 2024-02-05 | 2024-02-04 | MNKD | MANNKIND CORP | HOOPER ANTHONY C | Dir | A - Grant | $3.27 | +40.0K | 176.2K | +29% | +$130.8K | |
| D | 2023-06-20 | 2023-06-15 | ONC | BeOne Medicines Ltd. | HOOPER ANTHONY C | Dir | A - Grant | $0.00 | +12.9K | 37.4K | +53% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | BeOne Medicines Ltd. | HOOPER ANTHONY C | Dir | A - Grant | $0.00 | +16.7K | 24.5K | +214% | $0 |
| 2022-03-01 | 2022-02-28 | MNKD | MANNKIND CORP | HOOPER ANTHONY C | Dir | P - Purchase | $2.71 | +40.0K | 338.4K | +13% | +$108.4K |
Purchase Sale Sale after option exercise All abbreviations